Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vinod Mattoo"'
Autor:
Rajeev Chawla, Siddhesh Kolwankar, Maaz Shaikh, Aravind Sosale, Banshi Saboo, Abhishek Shah, Vinod Mattoo, Arjun Krishnakumar, Ritika Verma, Shilpa Joshi
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 3, p e17908 (2021)
Journal of Medical Internet Research
Journal of Medical Internet Research
Background Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs for the treatment, prevention, or management of a medical disorder or disease. Many studies in the western population have shown the
Autor:
Shilpa Joshi, Rishi Rajat Adhikary, Vinod Mattoo, Banshi Saboo, Arjun Krishnakumar, Vasanth Kumar, Varsha Khatry, Sidddhesh Kolwankar
Publikováno v:
Diabetes. 69
Background: High out of pocket expenses have led to poor diabetes self-management and glycemic control in India. This study evaluates the impact of an iPDM (integrated personalized diabetes management) on blood glucose (BG) control. Methods: Study pa
Autor:
Arjun Krishnakumar, Ritika Verma, Rajeev Chawla, Aravind Sosale, Banshi Saboo, Shilpa Joshi, Maaz Shaikh, Abhishek Shah, Siddhesh Kolwankar, Vinod Mattoo
BACKGROUND Digital therapeutics are evidence-based therapeutic interventions driven by high-quality software programs for the treatment, prevention, or management of a medical disorder or disease. Many studies in the western population have shown the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86e016d396d7029ca361942c1424dd25
https://doi.org/10.2196/preprints.17908
https://doi.org/10.2196/preprints.17908
Autor:
Kirti Samudra, Abhishek Shah, Arjun Krishnakumar, Hemant Thacker, Tejal Lathia, Shilpa Joshi, Shehla Sajid Shaikh, Vinod Mattoo, Varsha Khatry, Rajeev Chawla
Publikováno v:
Diabetes. 68
Background: The glycaemic control among people with diabetes in India is very poor. This study evaluated the effectiveness an iPDM (integrated personalised self-management) in changing health behavior to improve blood glucose levels. Methods: We used
Autor:
Behram Pardiwala, Rommel Idnani, Varsha Khatry, Abhishek Shah, Rajeev Chawla, Shilpa Joshi, Vikrant Shah, Arjun Krishnakumar, Vinod Mattoo, Sharat Kolke
Publikováno v:
Diabetes. 68
Background: Diabetes self-reported clinical and lifestyle journey by the patient is very poor in India, unless significant additional time is spent by HCPs during appointments. We explored the use of an iPDM (integrated personalized self-management)
Autor:
Vinod Mattoo, Abhishek Shah, Arjun Krishnakumar, Rishi Adhikary, Snehal Sanghavi, Siddhesh Kolwankar
Publikováno v:
Journal of the American College of Cardiology. 75:3583
In South Asia, the increasing prevalence of hypertension and diabetes is a major threat to public health. Culturally adapted digital therapeutics (DTx) delivered via a mobile app to patients are an effective tool to deliver evidence-based interventio
Autor:
Vinod Mattoo, David Eckland, Debbie Knight, Carmen Fajardo, M. H. Tan, Mario Widel, Jorma Strand, Loren D. Grossman, Santiago Duran, David Oakley
Publikováno v:
Clinical Therapeutics. 27:554-567
Type 2 diabetes mellitus (DM) is a progressive disease. Initial therapy begins with dietary and lifestyle modifications. However, as the disease progresses, glycemic control becomes more difficult to attain, often requiringor =1 oral antihyperglycemi
Publikováno v:
Diabetes, Obesity and Metabolism. 5:311-316
Aim: To compare pre-meal injection of Humalog® Mix50™ (Mix50) and Humalog® Mix25™ (Humalog® Mix75/25™ in the US; Mix25) with respect to 2 h postprandial (2 h pp) blood glucose (BG) control after a carbohydrate-rich breakfast in patients with
Autor:
L.K. Levitt, M. Schwarzenhofer, H. Tounsi, Zvonko Milicevic, Vinod Mattoo, N. Rais, L.H.C. Liong, James Malone, A. Ekangaki
Publikováno v:
Diabetes Research and Clinical Practice. 59:137-143
Objective: To compare insulin lispro Mix25 and human insulin 30/70 with regard to their effect on morning and evening postprandial glucose (PPG) control, and on average daily blood-glucose (BG), in patients with Type 2 diabetes who wish to fast durin
Publikováno v:
Diabetes Research and Clinical Practice. 50:42